Aβ Extraction from Murine Brain Homogenates.

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Alzheimer's disease is characterized by beta-amyloid (Aβ) plaque accumulation in the brain.
• Accurate quantification of soluble and insoluble Aβ species is crucial for understanding disease progression.
• Existing methods for Aβ extraction can be complex and may not efficiently isolate all Aβ forms.

Purpose of the Study:

• To detail a robust protocol for the sequential extraction of soluble and insoluble beta-amyloid (Aβ) from transgenic murine brain homogenates.
• To provide a method amenable to downstream analysis techniques like western blotting and ELISAs.
• To facilitate the assessment of amyloidogenic burden in preclinical models.

Main Methods:

• Mechanical homogenization of transgenic murine brain tissue.
• Sequential extraction using diethylamine (DEA) for soluble proteins (including Aβ isoforms and APP).
• Extraction of insoluble protein aggregates (plaque-associated Aβ) using formic acid.

Main Results:

• The protocol yields distinct soluble and insoluble protein fractions.
• These fractions contain specific Aβ isoforms and related proteins.
• The extracted Aβ species are suitable for sensitive detection methods.

Conclusions:

• This protocol provides a reliable method for separating and extracting soluble and insoluble Aβ species from brain tissue.
• The extracted Aβ is readily analyzable by western blotting and ELISAs.
• This technique is valuable for quantifying amyloid burden in animal studies.